Deep Brain Stimulation Devices Market Size, Share, Growth and Forecast 2018-2026

The latest market report published by Credence Research, Inc. the global market for deep brain stimulation devices was valued at US$ 699.6 million in 2017 and is expected to reach US$ 1,889.4 million by 2026, increasing to CAGR by 11.6 percent from 2018 to 2026.

Market Insights

Since the first application of deep brain stimulation (DBS) in the 1990s, indications for the potential use of deep brain stimulation devices have increased. At present, more than 1.5 million individuals have received DBS treatment for a number of approved and off-label indications. Reversibility and titrability are the key features of deep brain stimulation devices that increase their appeal in the field of clinical neurology. Despite their perceived advantages, the USFDA has been cautious about the approval and widespread adoption of deep brain stimulation treatments. Parkinson’s disease, epilepsy and tremor have been approved by the FDA, with the exception of dystonia and obsessive compulsive disorders on humanitarian grounds. Conversely, the European Commission is more liberal in granting direct approval to these conditions. The DBS has been applied for several conditions with proven benefits. However, due to the scarcity of the number of procedures, there is a lack of robust evidence due to the difficulty of performing double-blind randomized trials under such conditions.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/deep-brain-stimulation-devices-market

As the global burden of neurological diseases is increasing, the healthcare infrastructure worldwide is increasing its efforts to implement and integrate new treatment methods and modalities that will help to reduce the always-increasing number of conditions. Therefore, high morbidity has created a clinical urgency for long-term treatment options such as deep brain stimulation. Deep brain stimulation devices have proven evidence to have an important role in offering potential treatment to conditions such as epilepsy, tremors, and Parkinson's disease, and are being further explored for their viability in other neurological areas.

Advancements in deep brain stimulation device technologies are shaping the growth of this market. Some of such advancements include customized programming, robot-assisted implantations, integrated pulse generators, and so on. Such progresses have allowed better treatment outcomes and safety profile to deep brain stimulation devices, particularly in treatment of movement disorders. At present, among the several approved applications of deep brain stimulation devices, Parkinson's disease dominates the global market both in terms of revenue and volume. Parkinson's disease is a common neurological disease with less treatment alternatives, and the available treatments are often administered for life. Long-term costs of Parkinson's medications have led to increased adoption of deep brain stimulation devices, therefore gaining a greater market share. Additionally, the recently approved epilepsy application is expected to undergo the fastest growth during the forecast period. Lower therapeutic response to medication and lower outcomes from surgeries will urge chronic patients to adopt deep brain stimulation as a potential treatment.

The global deep brain stimulation devices market is highly competitive and consolidated. The market is characterized by the presence of limited number of players. The major companies operating in this market are engaged in developing next generation devices that shall deliver better treatment outcomes, with expanded application areas with legal sanction. The companies are also actively engaged expanding their geographical reach, and improving distribution channels with partnerships and distribution agreements.

Key Market Movements:

• Growing prevalence of neurodegenerative diseases such as Parkinson's disease and other movement disorders
• Lack of availability of viable and more efficacious treatment options for such diseases
• Growing preference of neurostimulation devices for treatment of neurological conditions
• Intensive marketing strategies in North America and Europe
• Intensive research and development activities promoting the efficacy of DBS devices

The prime players operating in the global deep brain stimulation devices market are Medtronic Plc, Boston Scientific Corporation, Abbott (St. Jude Medical, Inc.), Aleva Neurotherapeutics SA, NeuroPace, Inc., PINS Medical Co., Ltd.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59327

Table of Content

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I - Secondary Research
1.4.2. Phase II - Primary Research
1.4.3. Phase III - Expert Panel Review
1.4.4. Assumptions
 1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Deep Brain Stimulation Devices Market Portraiture
2.2. Global Deep Brain Stimulation Devices Market, by Modality, 2017 (US$ Mn)
2.3. Global Deep Brain Stimulation Devices Market, by Application, 2017 (US$ Mn)
 2.4. Global Deep Brain Stimulation Devices Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Deep Brain Stimulation Devices Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
 3.6. Competitive Analysis: Global Deep Brain Stimulation Devices Market, by Key Players, 2017

Chapter 4. Global Deep Brain Stimulation Devices Market, by Modality, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Subthalamic Nucleus (STN) DBS
4.3. Globus Pallidus Interna (GPi) DBS
 4.4. Thalamus (Vim) DBS

Chapter 5. Global Deep Brain Stimulation Devices Market, by Application, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Parkinson’s Disease
5.3. Epilepsy
5.4. Obsessive Compulsive Disorder (OCD)
5.5. Dystonia
 5.6. Essential Tremors

Chapter 6. Global Deep Brain Stimulation Devices Market, by Geography, 2016 - 2026 (US$ Mn)
 .........................

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59327

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com